Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Veracyte. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Veracyte.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Veracyte Inc addetti ai lavori?
A Veracyte Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 24.52K azioni del valore di $1.14M, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno ottobre 3, 2025, Annie McGuire, l'azienda SVP, GENERAL COUNSEL sold 2.16K condivisioni per $35 ciascuna.
- Il giorno settembre 23, 2025, Annie McGuire, l'azienda SVP, GENERAL COUNSEL sold 2.28K condivisioni per $33.69 ciascuna.
- Il giorno ottobre 3, 2025, John Leite, l'azienda CHIEF COMMERCIAL OFFICER-CLIA sold 2.54K condivisioni per $35 ciascuna.
Statistiche sulla proprietà per Veracyte Inc
Numero di azioni emesse
78.672M
Azioni possedute dagli insider
1.671M
Percentuale posseduta dagli Insider
2.12%
Azioni possedute dagli investitori istituzionali
74.496M
Percentuale posseduta dagli investitori istituzionali
94.7%
Oct 07, 2025 | CHIEF SCIENTIFIC & MED OFFICER | -8.35K | $36.02 | -$300.71K | SELL | -8.28% | 92.44K | Oct 06 | ||
Oct 03, 2025 | CHIEF COMMERCIAL OFFICER-CLIA | -2.54K | $35.00 | -$88.86K | SELL | -2.77% | 89.10K | Oct 01 | ||
Oct 03, 2025 | DIRECTOR | -11.47K | $21.51 | -$673.80K | SELL | -15.52% | 62.45K | Oct 01 | ||
Oct 03, 2025 | SVP, GENERAL COUNSEL | -2.16K | $35.00 | -$75.61K | SELL | -2.36% | 89.44K | Oct 01 | ||
Sep 23, 2025 | SVP, GENERAL COUNSEL | -2.28K | $33.69 | -$76.92K | SELL | -2.43% | 91.60K | Sep 19 | ||
Sep 08, 2025 | CHIEF EXECUTIVE OFFICER | -7.67K | $30.41 | -$233.13K | SELL | -2.24% | 334.19K | Sep 04 | ||
Jun 17, 2025 | DIRECTOR | -4.59K | $26.66 | -$122.39K | SELL | -24.81% | 13.91K | Jun 13 | ||
Jun 17, 2025 | DIRECTOR | -4.59K | $26.67 | -$122.37K | SELL | -13.27% | 29.99K | Jun 13 | ||
Jun 06, 2025 | CHIEF COMMERCIAL OFFICER-CLIA | -2.81K | $27.20 | -$76.41K | SELL | -2.89% | 94.54K | Jun 04 | ||
Mar 10, 2025 | CHIEF COMMERCIAL OFFICER-CLIA | 28.83K | $31.66 | -$234.63K | GRANT | 40.37% | 100.25K | Mar 06 - Mar 07 | ||
Mar 06, 2025 | CHIEF SCIENTIFIC & MED OFFICER | -8.04K | $33.35 | -$268.01K | SELL | -8.87% | 82.54K | Mar 04 | ||
Mar 06, 2025 | CHIEF EXECUTIVE OFFICER | -52.70K | $33.34 | -$1.76M | SELL | -16.43% | 268.04K | Mar 04 | ||
Mar 06, 2025 | SVP, GENERAL COUNSEL | -1.14K | $33.69 | -$38.48K | SELL | -1.60% | 70.31K | Mar 04 | ||
Mar 03, 2025 | CHIEF COMMERCIAL OFFICER-CLIA | -2.39K | $34.37 | -$460.36K | SELL | -3.24% | 71.42K | Feb 27 - Mar 02 | ||
Feb 05, 2025 | CHIEF FINANCIAL OFFICER | -527.00 | $43.85 | -$23.11K | SELL | -0.46% | 113.51K | Feb 03 | ||
Jan 06, 2025 | DIRECTOR | 0.00 | $22.79 | -$350.21K | SELL-OPTIONS | 0.00% | 18.50K | Jan 02 | ||
Dec 17, 2024 | CHIEF EXECUTIVE OFFICER | -5.59K | $43.42 | -$242.74K | SELL | -1.79% | 307.35K | Dec 13 | ||
Dec 06, 2024 | CHIEF SCIENTIFIC & MED OFFICER | -3.93K | $44.09 | -$173.45K | SELL | -4.56% | 82.41K | Dec 04 | ||
Dec 06, 2024 | SVP, GENERAL COUNSEL | -18.70K | $44.02 | -$823.18K | SELL | -20.42% | 72.87K | Dec 04 | ||
Dec 04, 2024 | CHIEF COMMERCIAL OFFICER-CLIA | -2.36K | $43.73 | -$103.38K | SELL | -3.10% | 73.81K | Dec 02 - Dec 03 | ||
Dec 04, 2024 | CHIEF FINANCIAL OFFICER | -10.46K | $43.53 | -$455.45K | SELL | -8.40% | 114.04K | Dec 02 - Dec 03 | ||
Dec 04, 2024 | VP, CHIEF ACCOUNTING OFFICER | -2.04K | $43.76 | -$89.41K | SELL | -4.83% | 40.27K | Dec 02 - Dec 03 | ||
Nov 29, 2024 | VP, CHIEF ACCOUNTING OFFICER | -5.03K | $42.89 | -$215.83K | SELL | -10.63% | 42.31K | Nov 27 | ||
Nov 21, 2024 | DIRECTOR | -14.73K | $38.34 | -$564.77K | SELL | -44.33% | 18.50K | Nov 19 | ||
Nov 14, 2024 | CHIEF FINANCIAL OFFICER | -15.28K | $38.34 | -$585.66K | SELL | -10.93% | 124.50K | Nov 12 | ||
Nov 14, 2024 | DIRECTOR | 0.00 | $23.18 | -$454.23K | SELL-OPTIONS | 0.00% | 44.60K | Nov 12 | ||
Sep 23, 2024 | DIRECTOR | -5.17K | $35.23 | -$182.26K | SELL | -13.09% | 34.34K | Sep 19 | ||
Sep 06, 2024 | CHIEF COMMERCIAL OFFICER-CLIA | -5.48K | $29.78 | -$163.16K | SELL | -6.71% | 76.17K | Sep 04 | ||
Aug 14, 2024 | DIRECTOR | -39.36K | $21.30 | -$1.45M | SELL | -88.38% | 5.17K | Aug 12 - Aug 13 | ||
Aug 13, 2024 | DIRECTOR | -1.48K | $20.22 | -$50.27K | SELL | -4.35% | 32.46K | Aug 09 | ||
Aug 09, 2024 | DIRECTOR | -5.00K | $29.00 | -$145.00K | SELL | -15.21% | 27.88K | Aug 07 | ||
Aug 09, 2024 | DIRECTOR | -3.89K | $20.37 | -$142.25K | SELL | -4.62% | 80.35K | Aug 07 | ||
Jul 18, 2024 | DIRECTOR | -7.50K | $25.00 | -$187.50K | SELL | -18.41% | 33.23K | Jul 16 | ||
Jul 18, 2024 | CHIEF COMMERCIAL OFFICER-CLIA | -1.28K | $25.00 | -$31.93K | SELL | -1.52% | 82.97K | Jul 16 | ||
Jul 18, 2024 | DIRECTOR | -5.00K | $24.50 | -$122.50K | SELL | -13.20% | 32.88K | Jul 16 | ||
Jun 13, 2024 | DIRECTOR | -3.87K | $20.59 | -$79.68K | SELL | -11.68% | 29.25K | Jun 11 | ||
Jun 11, 2024 | DIRECTOR | -3.87K | $20.32 | -$78.63K | SELL | -14.35% | 23.11K | Jun 10 | ||
Jun 11, 2024 | DIRECTOR | 0.00 | $15.69 | -$26.40K | SELL-OPTIONS | 0.00% | 33.13K | Jun 07 | ||
May 30, 2024 | DIRECTOR | -1.54K | $21.00 | -$32.32K | SELL | -5.40% | 26.98K | May 28 | ||
Apr 02, 2024 | DIRECTOR | 0.00 | $17.42 | -$84.63K | SELL-OPTIONS | 0.00% | 33.13K | Apr 01 | ||
Mar 05, 2024 | DIRECTOR | 0.00 | $18.77 | -$111.70K | SELL-OPTIONS | 0.00% | 72.77K | Mar 01 | ||
Jul 24, 2023 | DIRECTOR | -3.93K | $30.17 | -$118.49K | SELL | -10.05% | 35.17K | Jul 19 | ||
Jul 19, 2023 | DIRECTOR | 0.00 | $18.31 | -$477.60K | SELL-OPTIONS | 0.00% | 33.13K | Jul 17 - Jul 18 | ||
Jul 19, 2023 | DIRECTOR | -52.81K | $30.09 | -$1.59M | SELL | -57.99% | 38.26K | Jul 17 - Jul 18 | ||
Jun 21, 2023 | DIRECTOR | -5.89K | $26.44 | -$155.79K | SELL | -17.13% | 28.51K | Jun 16 | ||
Jun 01, 2023 | DIRECTOR | -1.54K | $25.91 | -$39.88K | SELL | -5.86% | 24.73K | May 30 | ||
Apr 18, 2023 | DIRECTOR | 0.00 | $13.82 | -$558.62K | SELL-OPTIONS | 0.00% | 177.48K | Apr 14 | ||
Mar 17, 2023 | DIRECTOR | 0.00 | $17.45 | -$199.79K | SELL-OPTIONS | 0.00% | 23.45K | Mar 16 | ||
Mar 16, 2023 | DIRECTOR | 0.00 | $14.19 | -$583.15K | SELL-OPTIONS | 0.00% | 177.48K | Mar 15 | ||
Mar 02, 2023 | DIRECTOR | 0.00 | $18.56 | -$128.80K | SELL-OPTIONS | 0.00% | 23.45K | Feb 28 | ||
Jan 18, 2023 | DIRECTOR | 0.00 | $15.98 | -$705.10K | SELL-OPTIONS | 0.00% | 186.47K | Jan 17 | ||
Jan 12, 2023 | DIRECTOR | 0.00 | $19.73 | -$682.23K | SELL-OPTIONS | 0.00% | 186.47K | Jan 11 | ||
Dec 16, 2022 | DIRECTOR | -600.00 | $30.13 | -$18.08K | SELL | -0.50% | 119.84K | Dec 14 | ||
Dec 15, 2022 | DIRECTOR | -1.67K | $30.71 | -$51.20K | SELL | -1.37% | 120.44K | Dec 13 | ||
Dec 08, 2022 | CHIEF SCIENTIFIC & MED OFFICER | -1.02K | $27.03 | -$27.65K | SELL | -1.53% | 65.97K | Dec 06 | ||
Dec 05, 2022 | EXECUTIVE CHAIRWOMAN | 0.00 | $19.66 | -$1.38M | SELL-OPTIONS | 0.00% | 188.52K | Dec 01 | ||
Nov 15, 2022 | CHIEF SCIENTIFIC & MED OFFICER | 0.00 | $21.84 | -$30.00 | SELL-OPTIONS | 0.00% | 68.00K | Nov 11 | ||
Nov 15, 2022 | DIRECTOR | -6.00K | $30.23 | -$181.36K | SELL | -4.68% | 122.10K | Nov 11 | ||
Nov 08, 2022 | CHIEF SCIENTIFIC & MED OFFICER | -1.02K | $25.00 | -$25.57K | SELL | -1.48% | 68.00K | Nov 04 | ||
Aug 09, 2022 | EXECUTIVE CHAIRWOMAN | -121.92K | $27.56 | -$3.36M | SELL | -40.45% | 179.47K | Aug 05 - Aug 08 | ||
Aug 09, 2022 | CHIEF SCIENTIFIC & MED OFFICER | 9.68K | $17.19 | -$27.24K | SELL-OPTIONS | 16.04% | 70.03K | Aug 05 | ||
Jun 16, 2022 | DIRECTOR | 6.01K | $16.27 | -$141.85K | GRANT | 56.07% | 16.73K | Jun 14 - Jun 16 | ||
Jun 13, 2022 | CHIEF EXECUTIVE OFFICER | 60.00K | $16.33 | $980.09K | BUY | 60.14% | 159.76K | Jun 10 | ||
Jun 10, 2022 | DIRECTOR | 0.00 | $12.95 | -$166.65K | SELL-OPTIONS | 0.00% | 8.72K | Jun 08 | ||
Mar 07, 2022 | CHIEF SCIENTIFIC & MED OFFICER | 23.82K | $15.55 | -$551.43K | SELL-OPTIONS | 63.38% | 61.39K | Mar 03 - Mar 04 | ||
Dec 20, 2021 | DIRECTOR | 0.00 | $28.56 | -$164.40K | SELL-OPTIONS | 0.00% | 8.72K | Dec 17 | ||
Dec 08, 2021 | CHIEF SCIENTIFIC & MED OFFICER | -1.08K | $27.84 | -$322.52K | SELL | -2.20% | 47.91K | Dec 06 - Dec 07 | ||
Nov 03, 2021 | DIRECTOR | -4.40K | $27.27 | -$119.97K | SELL | -33.54% | 8.72K | Nov 01 | ||
Sep 21, 2021 | EXECUTIVE CHAIRWOMAN | -2.60K | $50.18 | -$130.48K | SELL | -0.91% | 282.02K | Sep 17 | ||
Sep 14, 2021 | EXECUTIVE CHAIRWOMAN | -1.90K | $50.03 | -$95.05K | SELL | -0.66% | 284.62K | Sep 10 | ||
Sep 09, 2021 | CHIEF SCIENTIFIC & MED OFFICER | -926.00 | $33.66 | -$470.05K | SELL | -1.82% | 50.05K | Sep 07 - Sep 08 | ||
Aug 04, 2021 | DIRECTOR | -4.40K | $43.91 | -$193.19K | SELL | -25.11% | 13.12K | Aug 02 | ||
Jun 25, 2021 | CHIEF SCIENTIFIC & MED OFFICER | 0.00 | $32.22 | -$65.89K | SELL-OPTIONS | 0.00% | 51.89K | Jun 23 | ||
Jun 08, 2021 | CHIEF SCIENTIFIC & MED OFFICER | -925.00 | $23.58 | -$212.38K | SELL | -1.75% | 51.89K | Jun 04 | ||
Jun 04, 2021 | DIRECTOR | 2.00K | $35.19 | $70.39K | BUY | ∞ | 2.00K | Jun 03 | ||
May 05, 2021 | DIRECTOR | -4.43K | $48.27 | -$213.70K | SELL | -33.47% | 8.80K | May 03 | ||
Mar 08, 2021 | CHIEF SCIENTIFIC & MED OFFICER | -21.05K | $34.08 | -$1.98M | SELL | -28.15% | 53.72K | Mar 04 | ||
Feb 26, 2021 | DIRECTOR | 0.00 | $32.35 | -$354.36K | SELL-OPTIONS | 0.00% | 0.00 | Feb 25 | ||
Jan 15, 2021 | CHAIRMAN AND CEO | 0.00 | $28.33 | -$842.45K | SELL-OPTIONS | 0.00% | 251.66K | Jan 13 | ||
Jan 13, 2021 | CHAIRMAN AND CEO | 0.00 | $29.23 | -$3.90M | SELL-OPTIONS | 0.00% | 251.66K | Jan 11 - Jan 12 | ||
Jan 05, 2021 | DIRECTOR | 0.00 | $28.18 | -$415.90K | SELL-OPTIONS | 0.00% | 0.00 | Jan 04 | ||
Dec 04, 2020 | — | -1.09K | $33.98 | -$676.69K | TAX | -1.37% | 78.31K | Dec 02 - Dec 04 | ||
Nov 13, 2020 | — | 0.00 | $27.25 | -$397.24K | OPTION EXERCISE | 0.00% | 0.00 | Nov 12 | ||
Nov 13, 2020 | — | -13.88K | $45.00 | -$624.38K | SELL | -42.10% | 19.09K | Nov 11 | ||
Nov 09, 2020 | — | 0.00 | $31.83 | -$493.64K | OPTION EXERCISE | 0.00% | 74.31K | Nov 06 | ||
Nov 06, 2020 | — | 0.00 | $24.08 | -$212.75K | OPTION EXERCISE | 0.00% | 74.31K | Nov 05 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.